Abstract
With ageing, the potency of individual risk factors traditionally associated with common illnesses declines. Instead, it is becoming clear that the impact of a wide range of age-related deficits not traditionally considered as risk factors for these illnesses increases. These age-related deficits chiefly confer risk as a group, not individually. The many effects of age-related changes can be demonstrated epidemiologically, and in preclinical models, using a frailty index to distinguish between the contributions of traditional and non-traditional risk factors. Quantifying the contribution of age-related deficit accumulation in clinical and preclinical samples offers a powerful new tool for understanding mechanisms of age-related disease. It appears that a range of common late-life illnesses might be targeted by drugs aimed at ageing processes.
Original language | English |
---|---|
Pages (from-to) | 107-116 |
Number of pages | 10 |
Journal | Mechanisms of Ageing and Development |
Volume | 180 |
DOIs | |
Publication status | Published - Jun 2019 |
Bibliographical note
Funding Information:Canadian Institutes of Health Research (CIHR)for KR: PJT 156114; for SEH CIHR PJT 155961 and 162462. Both are also supported by the Fountain Family Innovation Fund of the Queen Elizabeth II Health Sciences Foundation.
Funding Information:
Canadian Institutes of Health Research (CIHR) for KR: PJT 156114 ; for SEH CIHR PJT 155961 and 162462 . Both are also supported by the Fountain Family Innovation Fund of the Queen Elizabeth II Health Sciences Foundation .
Publisher Copyright:
© 2019 The Authors
ASJC Scopus Subject Areas
- Ageing
- Developmental Biology